2023 FSP Annual Conference


Save the date for the FSP's 49th Annual Pathology Conference Updates and Practical Approaches in Pathology taking place on February 17-19, 2023 at Disney's Contemporary Resort in Orlando, FL. We hope to see you there!



Featured Keynote Faculty

Debra A. Bell, MD
Division of Anatomic Pathology
Department of Laboratory Medicine and Pathology
Professor of Laboratory Medicine and Pathology
Mayo Clinic
Rochester, MN
Topic: GYN Pathology

L. Jeffrey Medeiros, MD
Professor and Chair
Department of Hematopathology
The University of Texas MD Anderson Cancer Center
Houston, TX
Topic: Hematopathology

Stuart J. Schnitt, M.D.
Chief of Breast Oncologic Pathology, Dana-Farber/Brigham and Women’s Cancer Center;
Associate Director,
Dana-Farber Cancer Institute/Brigham and Women’s Hospital Breast Oncology Program;
Professor of Pathology, Harvard Medical School
Boston, MA
Topic: Breast Pathology

Monkeypox Session Faculty

Hema Kapoor MD, D(ABMM)
Senior Medical Director, IDI, GDN
Quest Diagnostics
Miramar, FL

Microscopy Session Faculty

David Hernandez Gonzalo, MD
Clinical Associate Professor
Department of Pathology, Immunology and Laboratory Medicine; University of Florida
Gainesville, FL

Educational Symposium Faculty

Monica Garcia-Buitrago, MD
Professor Clinical Pathology
University of Miami Miller School of Medicine
Miami, FL
Topic: Patterns of Colitis: The Old and the New

Elizabeth Montgomery, MD
Professor of Pathology
University of Miami
Miami, FL
Topic: Approach to Gastric Polyps: How it all MAPS out

Nemencio Ronquillo Jr., MD
Clinical Assistant Professor
University of Miami Miller School of Medicine
Miami, FL
Topic: Pattern-based approach to liver biopsies

Rhonda K. Yantiss, MD
Professor of Pathology
University of Miami
Miami, FL
Topic: Patterns of Esophagitis: Beyond Reflux and EoE

Rare and Interesting Case Presenters

Luiz Paulo de Lima Guido, MD
Resident (PGY-4)
Department of Pathology and Laboratory Medicine
Jackson Memorial Hospital-University of Miami Miller School of Medicine
Miami, FL

Wen Lin
Biomedical Science Undergrad
University of South Florida
Tampa, FL

Diego M. Montoya-Cerrillo, MD
Chief Resident, PGY 4
Department of Pathology and Laboratory Medicine
University of Miami/ Jackson Memorial Hospital
Miami, FL

Christopher B. Ryder, MD, PhD
Assistant Member, Department of Pathology; Assistant Professor, Department of Oncologic Sciences
Moffitt Cancer Center; University of South Florida Morsani School of Medicine
Tampa, FL

Sunaina Shrestha, MBBS
Medical Resident, PGY-1
College of Medicine, University of Florida
Gainesville, FL


To view the presentation slides please log in to your account

Friday, February 17, 2023

8:00 am - 7:30 pm
Registration Open   


9:00 am - 10:30 am


9:00 am - 9:30am -- Digital and AI-Empowered Pathology: Opportunities
Piotr Borkowski, MD


9:30 am - 10:00 am -- H&E Based Computational Predictive and Prognostic Markers in cancer diagnostics
Juan Retamero, MD


10:00 am - 10:30 am -- Molecular testing in a Digital Pathology Age: decreasing time to treatment
Mark C. Kruzel, MD, MBA


10:30 am - 12:00 pm
EDUCATIONAL SYMPOSIUM HOSTED BY UM: Interactive GI Pathology: A practical approach to GI biopsies


Pattern-based approach to liver biopsies
Nemencio R. Ronquillo, Jr. MD


Approach to Gastric Polyps, Dysplasia and Adenomas: How it all MAPS out!
Elizabeth Montgomery, MD


Patterns of Colitis: The Old and the New
Monica Garcia-Buitrago, MD


Patterns of Esophagitis: Beyond Reflux and EoE
Rhonda K. Yantiss, MD


12:00 pm - 12:45 pm
Non-CME Product Theater
Lunch served


1:00 pm - 1:15 pm


1:15 pm - 2:15 pm
2020 WHO Classification of Female Genital Tumors: New Entities and Important Changes
Debra A. Bell, MD


2:15 pm - 3:15 pm
Serous Neoplasms of the Ovary and Fallopian Tube: A Survival Guide
Debra A. Bell, MD


3:15 pm - 3:45 pm
Refreshment Break with Exhibitors and Poster Sessions  


3:45 pm - 4:45 PM
New Entities in Gynecologic Pathology Microscopy Session
Debra A. Bell, MD


4:45 pm - 5:30 pm
Microscopy Read Slides Session- GI Pathology
David Hernandez Gonzalo, MD


5:45 pm - 6:30 pm
Updates on Monkeypox (Non-CME)
Hema Kapoor, MD, SM, D(ABMM)


6:30 pm - 7:30 pm
Welcome Reception with Exhibitors
Sponsored by College of American Pathologists


Saturday, February 18, 2023

7:00 am - 4:30 pm
Registration Open  


7:00 am - 7:45 am
Non-CME Product Theater
Breakfast Served


7:00 am - 8:00 am
Breakfast with Exhibitors and Poster Sessions   


7:55 am - 8:00 am
Morning Notes and Overview   


8:00 am - 9:00 am
Diffuse large B-cell lymphoma: An update
L. Jeffrey Medeiros, MD


9:00 am - 10:00 am
Histiocytic and Dendritic Cell Lesions
L. Jeffrey Medeiros, MD


10:00 am - 10:45 am
Refreshment Break with Exhibitors and Poster Sessions  


10:45 am - 11:45 am
Potpourri of Lymph Node Lesions Microscopy Session
L. Jeffrey Medeiros, MD


12:00 pm - 12:45 pm
Non-CME Product Theater
Lunch Served


1:00 pm - 1:30 pm
FSP Business Meeting   


1:30 pm - 1:50 pm
Recent, Ongoing, and Future Legal Matters Affecting Your Practice
Steven Weinstein and Patrick Montoya


1:50 pm - 2:00 pm
An Update from the FMA
Ronald Giffler, MD


2:00 pm - 2:30 pm
CAP Advocacy Update
Emily E. Volk, MD, FCAP, CAP President


2:30 pm - 3:30 pm
Rare and Interesting Case Session   


3:30 pm - 4:30 pm
Non-CME Product Theater  


4:30 pm - 5:30 pm
Fellowship Fair and Reception   


6:30 pm - 10:00 pm
75th Anniversary Celebration
Sponsored by Caris Life Sciences


Sunday, February 19, 2023

7:00 am - 12:15 pm
Registration Open  


7:00 am - 8:00 am
Breakfast with Exhibitors   


8:00 am - 8:15 am
Morning Notes and Overview   


8:15 am - 9:15 am
The Challenge of Evaluating Post-Neoadjuvant Systemic Therapy Breast Specimens
Stuart J. Schnitt, MD


9:15 am - 10:15 am
Lobular carcinoma in situ and problematic in situ lesions
Stuart J. Schnitt, MD


10:15 am - 11:00 am
Refreshment Break with Exhibitors  


11:00 am - 12:00 pm
Unusual Breast Lesions Every Pathologist Needs to Know About Microscopy Session
Stuart J. Schnitt, MD


12:00 pm - 12:15 pm
Closing Remarks   



Disney’s Contemporary Resort
4600 World Dr
Lake Buena Vista, FL 32830

Room Rate:
The FSP discounted room rate starts at $339/night.

UPDATE as of January 6, 2023: The FSP room block for Disney's Contemporary Resort has officially sold out, however there are still rooms available under the FSP room block at Disney's Grand Floridian Resort which is a short monorail ride to the conference held at the Contemporary Resort. There are also rooms available at Disney's Animal Kingdom Lodge at the group rate. The Animal Kingdom Lodge is a short 10-minute drive from the Contemporary Resort. 

Room Reservation Deadline:
Attendees must first register for the meeting and once registered, will receive a confirmation email with the link and special code to book a room.


Accreditation Information

2023 FSP Annual Meeting
2023 FSP Annual Meeting



This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Florida Medical Association and the Florida Society of Pathologists. The Florida Medical Association is accredited by the ACCME to provide continuing medical education for physicians.

The Florida Medical Association designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Statements of credit/participation will be awarded based on the participant’s attendance at each session and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claim credit form at www.flpath.org/claimcme . If you have questions about this CME/CE activity, please contact the FSP at 904-309-6261. Credit must be claimed by March 1, 2023.


This activity is designed to meet the needs of practicing physicians, pathologists, and other specialists involved with pathology.

The field of pathology is constantly changing, and many of the most important advances in the field. In the setting of new technology, techniques and advancements in the field, practice gaps are inevitable. As such, pathologists require ongoing educational opportunities to stay current in order to maintain and improve their knowledge and competence in the field.


At the conclusion of this activity, all participants should be able to:

  • Recognize the clinicopathologic and immunophenotypic findings of Diffuse large B-cell lymphoma (DLBCL) as defined in the most recent 5th edition of the World Health Organization classification
  • Review diagnostic criteria for the major types of histiocytic lesions as recognized in the most recent 5th edition of the World Health Organization classification
  • Recognize diagnostic features and differential diagnosis in the evaluation of various lymph node lesions
  • Discuss the changes in the most recent WHO Classification of Female Genital Tumors
  • Review diagnostic criteria for serous borderline tumors, high- and low-grade serous carcinomas, and serous tubal intraepithelial carcinomas
  • Discuss the challenges posed by evaluating post-neoadjuvant therapy breast specimens
  • Describe the histologic features and clinical significance of classic and variant forms of lobular carcinoma in situ
  • Recognize diagnostic features and differential diagnosis in the evaluation of various neoplasms including breast, gastrointestinal and gynecologic neoplasms
  • Appraise unique pathology cases


All commercial support and educational grants will be communicated to attendees in advance of the meeting.



Qihui “Jim” Zhai, MD - Has nothing to disclose.

Margaret Neal, MD - Has nothing to disclose.

Carmen Gomez-Fernandez, MD - Has nothing to disclose.

Jesse Kresak, MD - Has nothing to disclose.

Philip Robinson, MD - Has nothing to disclose.

Robert P. Seifert, MD - Has nothing to disclose.

Piotr Borkowski, MD - Has nothing to disclose.

Adrian Palmer, MD - Has nothing to disclose.

Marilyn Bui, MD, PhD - All of the relevant financial relationships listed for this individual have been mitigated.

  • Grant/Research Support:
    • John Cleveland, PhD- Principal Investigator
    • Marusyk, PhD, Phillip Altrock, PhD, David Basanta, PhD- Co-Principal Investigator
    • Robert Gilles, PhD, Bethany Niell, MD, PhD- Co- Principal Investigator
  • Consultant/Advisor/Contractor:
    • 2019-2022 Scientific Advisory Board Member of ContextVision AB
    • 2020-Present Scientific Advisory Board Member of Aiforia Technologies Oy
    • 2020-2022 Scientific Advisory Board member of Visiopharm
    • 2020-2022 HER2-Low Pathology Advisory Board Member of AstraZeneca
    • Nov 13, 2020 RNA/GEP Scientific Advisory Board member of Foundation Medicine Institute
    • February-April 2021 Group leader of Advances in the Multidisciplinary Care of Patients with Tenosynovial Giant Cell Tumor on a virtual platform by Spire Learning.
    • July 7, 2021 Lete-cel Regional Steering Committee member of GlaxoSmithKline
    • Nov 7, 2021 Caris Life Sciences Advisory panel meeting
    • March, 26,2022 Sarcoma therapy BioAlas Advisory panel meeting
  • Speaker’s Bureau:
    • Feb 2, 2021 Merck
    • May 14-15 Osler Review Anatomic Pathology virtual slide review (bone and cytopathology)


Debra A. Bell, MD - Has nothing to disclose.

L. Jeffrey Medeiros, MD - Has nothing to disclose.

Nemencio R. Ronquillo, Jr. MD - Has nothing to disclose.

David Hernandez Gonzalo, MD - Has nothing to disclose.

Monica Garcia-Buitrago, MD - Has nothing to disclose.

Rhonda K. Yantiss, MD - Has nothing to disclose.

Stuart J. Schnitt, MD - All of the relevant financial relationships listed for this individual have been mitigated.

  • Consultant - Path Al
  • Grant/Research Support- Ibex

Elizabeth Montgomery, MD - All of the relevant financial relationships listed for this individual have been mitigated.

  • Consultant/Advisor/Contractor- Cernostics - Slide review for a Barrett esophagus project

Christopher B. Ryder, MD, PhD - Has nothing to disclose.

Wen Lin - Has nothing to disclose.

Sunaina Shrestha, MBBS - Has nothing to disclose.

Diego M. Montoya-Cerrillo, MD - Has nothing to disclose.

Luiz Paulo de Lima Guido, MD - Has nothing to disclose.



It is the policy of the Florida Medical Association (FMA) to ensure independence, objectivity and scientific rigor in all approved CME content. CME faculty must present evidence-based data, clarify off-label product use and disclose all relevant financial relationships to the audience. The ideas and opinions expressed during jointly provided events do not necessarily reflect those of the FMA, and the FMA’s approval of course content for AMA PRA Category 1 Credits™. does not constitute an endorsement of the ideas, positions or statements contained therein. Every effort has been made to ensure that all information provided by the joint provider is accurate and current. However, FMA does not accept responsibility for errors or omissions and accepts no liability for any resulting loss or damage. Attendees agree to participate in this CME activity with full knowledge and awareness that they waive any claim they may have against the FMA for injury or other damage that may result in any way from their participation in this activity.


Join us on February 17-19, 2023 at the FSP’s 49th Annual Pathology Conference!  Exhibitors will connect with 250-300 pathologists during the conference with over 15 hours of face-to-face time during networking functions.
Other benefits include:

  • Pre and post attendee lists.
  • Acknowledgement on the FSP website, meeting signage and mobile app.
  • Maximum exposure to attendees as attendees are encouraged to visit with sponsors to receive prize giveaways during breaks scheduled in the exhibit hall.
  • Between 2-6 complimentary badges depending on sponsorship level chosen.

Due to popular demand, exhibitors are encouraged to register early as we do anticipate on selling out! Please contact Paige Hay at exhibits@flpath.org if you have any questions regarding sponsorship.

Exhibitors may apply here!

*Exhibitor registration is now closed*

View/Download Prospectus

Satellite Events


Special Events


Welcome Reception

Friday, February 17 from 6:30 pm to 7:30 pm

The Welcome Reception will take place on Friday, February 17 in the FSP Exhibit Hall. This will be your chance to meet with the exhibitors and to catch up with colleagues at the end of the day with a cocktail and appetizers. There will be an interactive photo booth at the FSP membership booth in the exhibit hall, raffle drawings for a chance to win exciting prizes and most importantly the opportunity to meet our industry sponsors!

The FSP would like to thank the College of American Pathologists for sponsoring the Welcome Reception. 


FSP 75th Anniversary Celebration

Saturday, February 18 from 6:30 pm to 10:00 pm
Ticket Price: $25
Dress: Black Tie

The FSP will host a 75th Anniversary Celebration on Saturday, February 18 at Disney's Contemporary Resort. Come dressed to impress at this black tie event as we share in the many successes and memories of the past 75 years of FSP's history. Tickets are only $25 as we want as many members and friends to join us for this special celebration. The ticket price includes a plated dinner, open bar, live band, interactive photo booth and most importantly a special evening shared amongst friends. There will even be a special guest appearance from Disney characters for attendees to take pictures! Tickets can be purchased online when registering for the meeting. We hope to see you there!

The FSP would like to thank Caris Life Sciences for their gracious support of the 75th Anniversary Celebration!

FSP Fellowship Fair and Reception

Saturday, February 18 from 4:30 pm to 5:30 pm

The Florida Society of Pathologists (FSP) will host a Fellowship Fair during a cocktail reception on Saturday, February 18 from 4:30 pm to 5:30 pm. Residents will have a unique opportunity to learn about the various Florida pathology fellowship programs directly from the program representatives in attendance. Residents will be able to obtain valuable insight and first-hand knowledge in a casual and engaging setting during the cocktail reception.

Programs in attendance include:

  • Moffitt Cancer Center
  • Mount Sinai Medical Center
  • Broward County Medical Examiner
  • University of Miami

How to Sign Up:

If you are a fellowship program director and you are interested in securing a table, please contact Shana Harvey at membership@flpath.org

If you are a resident interested in attending the meeting and the fellowship fair, please register for the FSP conference. There is no separate registration for the Fellowship Fair, you only need to be registered for the conference.

Confirmed Exhibitors

Thank you to the following companies for their support of the FSP 2023 Annual Pathology Conference:


 AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.


Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications, and expertise, enabling customers to gain the insights they seek. Agilent's expertise and trusted collaboration give them the highest confidence in our solutions. Agilent focuses its expertise on six key markets, where we help our customers achieve their goals, including Food, Environmental and Forensics, Diagnostics, Pharmaceutical, Chemical and Energy, and Research.


                              Applied Spectral Imaging (ASI) is a global leader in biomedical imaging with a comprehensive product portfolio for Karyotyping, H&E, IHC and FISH analysis; providing Pathology, Cytogenetics and Research laboratories advanced imaging and analysis tools. Founded in 1993, ASI successfully develops, markets and services its products in more than 80 countries.



APS Medical Billing is a premier billing firm that provides expert billing and practice management solutions to pathology and laboratory practices nationwide. APS’ clients range in size from a single-physician practice to large, multi-site academic departments, reference and independent labs. The scope of our billing services and proven strategies allow APS to effectively bill for professional, technical and global components of anatomic and clinical pathology services.


Arkana Laboratories is a private pathology practice specializing in renal and neuropathology. Our mission is to improve patient care by advancing understanding of disease and providing world-class diagnostics. 


Our ambition is to push the boundaries of science to change the practice of medicine and transform the lives of cancer patients. We target the underlying biology of cancer in Immuno-Oncology, Tumor Drivers/Resistance, DNA Damage Response and Antibody Drug Conjugates. Utilizing precision medicine and biomarker-driven indications we look to dramatically improve five-year survival. Our focus on early disease stages and relapsed patients is to 1) identify and treat patients earlier with curative intent; and 2) support relapsed and refractory patients by tackling primary or acquired resistance.



Bayer is a global life sciences leader in healthcare and nutrition. Building on a 150-year legacy in healthcare, Bayer is committed to improving patient lives by developing therapies and delivering first-in-class educational and support programs to meet their needs. 

Get your molecular biomarker results in hours, not days or weeks! The revolutionary Idylla platform by Biocartis is a RAPID, automated PCR system that offers accurate molecular information from tissue or plasma in any laboratory setting. Get you results within 85-180 minutes from sample input, with under three minutes of hands-on time. For more information, visit our website: www.biocartis.com/us



Blueprint Medicines is a global precision therapy company that aims to invent life-changing medicines for people with cancer and blood disorders.


Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb , visit us at bms.com or follow us on LinkedIn, Twitter, YouTube, Facebook , Instagram.


Change Healthcare is a leading healthcare technology company, focused on insights, innovation and accelerating the transformation of the U.S. healthcare system. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes. Our platform and comprehensive suite of software, analytics, technology enabled services and network solutions drive improved results in the complex workflows of healthcare system payers and providers by enhancing clinical decision making, simplifying billing, collection, and payment processes, and enabling a better patient experience.


Corista DP3 delivers an extensive array of digital workflows along with analytical and collaborative tools. As an innovator in digital pathology, Corista has expanded its functionality to include Research and Education applications. DP3’s suite of pathology workflows and image analytics enables pathologists and scientists to better analyze, collaborate, communicate, teach and report. DP3 provides integrated access to all image scanning systems, LIS/EHR platforms and best-of-breed image analytics. Specialists receive digital consultations from across the globe, and researchers have a powerful platform upon which to develop and apply their algorithms. Corista: This is Integrated Pathology.


Cleveland Clinic Laboratories is dedicated to providing high-quality, clinically impactful pathology and laboratory diagnostic services combined with readily available consultation from experienced pathologists and laboratory scientists. With more than 100 pathologists, our laboratories offer excellence in anatomic pathology subspecialty services ensuring that every specimen submitted will be evaluated by a pathologist with a high level of diagnostic expertise.


We support the whole pathologist so you can excel in your practice with the latest educational resources, powerful career development tools, extensive networking opportunities, and unwavering advocacy for fair regulations in the corridors of health care legislation. Whether you are just starting out or have been in practice for many years, being a CAP member allows you to continuously evolve your skills, strengthen your practice, and support your profession.


An entire industry started with an idea. Founded in 2008, Caris Life Sciences® is on a mission to help patients, clinicians, researchers, and payors navigate, advance and reinvent cancer care. Our unique combination of expertise, proprietary technologies, clinical testing capabilities, and extensive library of clinical data enables us to advance precision medicine.


CSI Laboratories, a Fulgent Genetics company, is a national cancer testing laboratory with one mission: keeping our clients and their patients at the forefront of everything we do. Our priority is to manage testing with speed, precision, and care, only delivering testing that is medically necessary and clinically significant. 


Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients. Through the outstanding knowledge and commitment of our 15,000 employees worldwide, we create innovative new and generic medicines, and new methods of drug discovery and delivery. We share a passion for innovation, as well as compassion for the patients around the world who are in need of our medicines.


  Diagnexia is an international Pathology Services company with facilities in Chicago, Dublin and Exeter UK. Diagnexia enables your hospital to easily and rapidly send a case for a consultation to our expert subspecialists through our cloud-based platform, for quality and efficiency. We connect leading expert pathologists to your most challenging cases with the goal of positively impacting patient care. Our vision is to empower pathologists, by enhancing patient care.



Loxo@Lilly aims to create medicines that make life better for all those affected by cancer around the world.  Bringing together the focus and spirit of a biotech with the scale, resources, and heritage of Lilly, our team is focused on rapidly delivering impactful new medicines for people with cancer. Our approach centers on creating oncology medicines that unequivocally show early signs of clinical activity and will matter to patients.


Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.

With over 12 years’ experience in laser cassette printing technology, General Data Healthcare is an industry leader in providing barcode identification and tracking solutions. Our Laser Track cassette printers consistently produce sharp, crisp readable text and barcodes that deliver nearly 100% scan rates. Sidetrack ESPO delivers automated direct to slide printing and worry-free control slides. We offer a wide variety of high quality Made-in-the-USA small instruments, such as precision water baths/flotation workstations, paraffin dispensers, slide dryers, fume hoods, and much more. Visit www.general-data.com/healthcare to schedule a live interactive demo of any instrument in the comfort of your home or lab!

ImagineSoftware is the leading provider of medical billing automation software and revenue cycle management applications. Offering powerful technology solutions for medical billing offices, practices, and hospitals for over 20 years, ImagineSoftware currently serves more than 75,000 physicians across 43 specialties. ImagineSoftware solutions improve financial efficiency, build provider reputation, and ultimately improve the patient experience. For more information, visit imagineteam.com and follow us on Twitter @ImagineTeam.


At Innovative Science Press, we are dedicated to the advancement of pathologists by producing and disseminating educational textbooks. We believe that all pathologists deserve access to quality and affordable medical training in order to help their patients. For this reason, our books are written by some of the most prominent in the field and are reasonably priced. We provide steep discounts to residents and fellows to make our products more affordable and donate frequently to the under-served countries.


Molecular diagnostic testing for indeterminate thyroid nodules utilizing multi platform testing. ThyGeNEXT is an oncogenic mutation panel that helps identify malignant thyroid nodules and ThyraMIR is a proprietary microRNA gene expression assay that helps to clarify the risk of cancer in thyroid nodules.


KUBTEC X‑ray specimen imaging systems for pathology enable you to more accurately identify lesions, clips, tissue, and markers. Designed specifically for the gross room, KUBTEC provides 2D & 3D specimen imaging systems with the tools you need to reduce turnaround time for your patient’s specimen.


Labcorp Oncology offers a broad array of pathology and oncology testing services.  From screening for inherited cancers, diagnosis on solid tumor biopsies, bone marrow and blood, prognostic and predictive biomarker testing and treatment monitoring, LabCorp Oncology helps power informed decisions at every stage of cancer care.  With over 75 specialty trained and boarded pathologists, PhDs, and genetic counselors, 25 years of testing expertise, and an extensive network of laboratories across the United States, Labcorp Oncology has a broad range of experience and ability to approach diagnostic challenges throughout a patient's entire continuum of care.  By connecting insights from patients, practioners, clinical trials, health systems and managed care partners, LabCorp is committed to improving outcomes through the promise of precision medicine..


Medical Malpractice Insurance.  Comprehensive solutions and support for the Practice of Medicine, the Business of Medicine and the Regulation of Medicine.


Mayo Clinic Laboratories strives to ensure patients around the world have access to the most advanced diagnostic testing. Working with hospitals and health care providers worldwide, we deliver the latest in diagnostic testing to provide answers and improve outcomes for their patients. With the world’s most sophisticated test catalog, our testing incorporates scientific discoveries, cutting-edge technologies, and unparalleled expertise to solve the most rare and complicated cases. 


MedReceivables Advisor, LLC is a full service outsourcing medical billing company for the hospital based physician. Our company provides complete accounts receivable management services for hospital-based physicians.


At Merck, our goal is to translate breakthrough science into innovative oncology medicines.  As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry. 




Milestone Medical's mission is to reduce patient anxiety by standardizing and expediting the pre-analytical steps of the histopathology lab and the operating room specimen collection and transportation. In doing so, our goal is to enable superior quality, same-day diagnoses.  Milestone is proud to offer innovative solutions in 6 different fields:  Tissue Processing, Specimen Handling, Frozen sections, Cytology, Macro-Digital and Reagents.  See what we have to offer: https://www.milestonemed.com




MilliporeSigma, the life science business of Merck KGaA, Darmstadt, Germany, is a leading company for innovative and top-quality high-tech products in healthcare, life science, and performance materials. Cell Marque Tissue Diagnostics, now a part of the Sigma Aldrich portfolio of MilliporeSigma, offers extensive expertise in tissue detection. Our focus is on primary antibody development from IVD validation offerings to lab-developed tests. We also offer an innovative line of HistoCyte Cell Line Controls, research antibodies through our partnership with AbCam, and a timeless portfolio of routine and special stains for histology. We are your comprehensive partner for the histopathology workflow.


MLabs home

MLabs is a full-service reference laboratory, with more than 35 years’ experience providing state-of-the-science tools and expertise to help clinicians and patients choose the right clinical path. MLabs is part of Michigan Medicine – one of the largest hospital systems in the world, and one of the best – ranked #11 in the nation and #1 in the state by U.S. News and World Report.


In today’s ever changing healthcare environment, pathologists face unprecedented challenges and demands, especially with issues such as revenue cycle management, contract negotiations, compliance and strategic growth. Therefore, it is critical to find a business partner that understands the needs and issues of today’s pathology practice.

MSN’s staff offers more than 20 years of pathology billing experience, including work with hospital-based practices and outreach facilities. Our high-tech approach allows for more aggressive claims follow-up and collection activity to ensure that you collect more than just the “low hanging fruit.”

Combining these qualities with a corporate culture based on a passion for customer service, MSN has become one of the leading billing companies for pathology in the country.


NeoGenomics is a Florida-based premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic, and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the US and offer global capabilities with laboratories in Switzerland and Singapore.


Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologist’s workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to evaluate treatment options more effectively for patients and design new biomarkers for drug development so that every patient gets precise treatment options.


Founded in 1965, PathGroup is a premier provider of anatomic, clinical, molecular, and digital pathology laboratory services. Using a combination of the latest in proprietary and industry standard technology, PathGroup provides a comprehensive anatomic, clinical, and molecular laboratory test menu. Operating from 147,000 square-feet in Nashville, TN, the laboratory facility houses state-of-the-art automation and instrumentation, performing millions of laboratory tests each year to service more than 15,000 healthcare providers and over 175 hospitals across 25 states. Privately held and physician-centric, PathGroup offers the laboratory testing information necessary to help healthcare providers make clinically actionable treatment plans with their patients. For more information, visit pathgroup.com.



PathPresenter is the global image sharing platform for pathology. We are on a mission to help democratize access to the world’s pathology knowledge by connecting pathologists to the vast expertise of their colleagues globally and providing a practical platform to access and use best-in-class AI models. Founded in 2017 by dermatopathologist and digital pathology pioneer, Dr. Rajendra Singh, PathPresenter has been adopted by 30+ tier one medical institutions for clinical care, education, and research, and has built a thriving community of 45,000+ users in 172 countries to easily view and share digital pathology images and knowledge.


Physicians Independent Management Services, Inc. (PIMS) is a full service medical billing and practice management company specializing in anatomic pathology.




We provide private autopsies for families looking for answers after a loved ones death. These are non-forensic autopsies. We are looking for pathologists who may be interested in joining our group to work part time performing autopsies in the state of Florida.


Proscia is a software company that is accelerating pathology’s digital transformation to change the way we understand diseases like cancer. Our Concentric digital pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a data-driven discipline, unlocking new insights that accelerate discovery, improve patient outcomes, and fulfill the promise of precision care. Leading diagnostic laboratories and over 10 of the top 20 pharmaceutical companies rely on Proscia’s software each day.


Quest Diagnostics is the leader in diagnostic information services, including Advanced Diagnostics and related information services, such as molecular and biochemical genetics, cytogenetics, and molecular hematology-oncology. The company’s services combine state-of-the-art technologies in next generation sequencing and nucleic acids, special chemistry and biomarker detection with interpretative expertise and digital enablement to guide clinical decisions across the continuum of care.


Roche Indy is the North American headquarters of the world's largest biotech company, where more than 4,000 people work together to provide insights that help people around the world manage and improve personal health conditions. We lead the industry in the development of diagnostics products for cancer, cardiac health, infectious diseases, women's health and in diabetes management. Diagnostics informs 70 percent of clinical decisions, including the prevention, identification and treatment of diseases, and are a critical part of modern medicine as care becomes more personalized.



                                                                                     Seagen is a global biotechnology company dedicated to revolutionizing cancer care. We’re developing transformative therapies that make a meaningful difference in people’s lives.


We sell Nikon Microscopes to many Hospitals, Research Facilities, Pathology and Dermatology groups in Florida. SEO services Microscopes (all brands) in many of these facilities with our six trained technicians.


TELCOR provides billing software and services for pathology practices and laboratories to manage its revenue cycle. These solutions are built on the premise that every pathology practice and lab needs to get paid for the work they do in the most efficient manner. Our software and service solutions provide unparalleled visibility to billing and revenue cycle data allowing executives to identify trends and make sound business decisions. This visibility is key to increasing collections and minimizing operating costs thus positively impacting profitability. With multiple solutions, each using our software designed specifically for the laboratory industry, we have a solution for pathology practices and labs of any size.


ThyroSeq- the most comprehensive NGS test for thyroid nodules available. ThyroSeq Genomic Classifier (GC) test utilizes next-generation sequencing to analyze both DNA and RNA of 112 thyroid-related genes for four main classes of molecular alterations, including mutations, gene fusions, copy number alterations, and gene expression alterations. For more information, visit thyroseq.com.


University of Florida Health Pathology Laboratories is the largest academic outreach pathology laboratory in Florida, offering comprehensive pathology services to hospitals and physician groups throughout the state.  


This booth is to create awareness of our Pathology Consultation Services  with expertise in all aspects of Anatomic and Clinical  Pathology.  We boast world class name brand" pathologists right here in Florida.  Experts include Drs. Andrew Rosenberg in Bone and Soft Tissue Pathology.


Veracyte is a pioneering genomic diagnostics company. Our tests provide trustworthy and actionable ANSWERS that improve patient care when diagnostic test results are uncertain. Our tests leverage innovations in genomic technology and machine learning to enable a significantly more confident diagnosis than currently possible in challenging diseases such as thyroid cancer, lung cancer and idiopathic pulmonary fibrosis. We are creating new standards of care in the diagnosis of these diseases by enabling more patients to avoid unnecessary invasive procedures, speeding time to diagnosis and removing costs from the healthcare system.

                        Visiopharm® is a world leader in AI-driven precision pathology software. 
 Visiopharm’s pioneering image analysis tools support thousands of scientists, pathologists, and image analysis experts in academic institutions, biopharmaceutical industry, and diagnostic centers. Our AI-based image analysis and tissue mining tools support research and drug development research worldwide, while CE-IVD APPs support primary diagnostics. With the most advanced and sophisticated artificial intelligence and deep learning, Visiopharm delivers tissue data mining tools, precision results, and workflows. 

Vistapath was founded to accomplish a single mission: to modernize pathology by giving labs the tools they need to increase quality, consistency, and efficiency in grossing workflows. Designed by histotechnicians, and built by artificial intelligence experts, the Sentinel platform makes grossing fast, efficient, and easy.


Coming soon

FSP Welcomes Submissions for Poster Hall and Poster Competition

The Florida Society of Pathologists (FSP) Poster Review Committee invites the submission of posters for inclusion in the Poster Hall during the FSP’s Annual Pathology Conference taking place on February 17-19, 2023 at Disney’s Contemporary Resortin Orlando, Florida.  

The purpose of the FSP Poster Hall is to stimulate research, provide a venue to share innovative and effective educational programs, showcase unique research projects, and to encourage networking among pathologists.

All pathologists are invited to submit case-based posters or research-based posters for inclusion in the Poster Hall. Residents and fellows are eligible to compete in the FSP Poster Competition for prizes.

Back by popular demand, residents and fellows who are enrolled in a full-time approved training program in pathology or sub-specialty of pathology are invited to submit and be eligible to participate in the FSP Poster Competition.

The poster author must register for the conference and pay a poster fee of $50 (included on the registration form). All e-posters must be submitted online once the submission portal opens. If your poster is not selected for display in the poster hall, FSP will provide a refund of this fee. Please add @flpath.org to your email "safe senders" or whitelist to ensure you receive important notifications from FSP.


Poster Submission Deadline
Monday, January 16, 2023
5:00 pm EST


Poster Submission Instructions
Please read through the submission instructions below before preparing your poster:

  1. Register for the Conference and pay the meeting registration and $50 poster fee.If you wish to submit more than 1 poster, you can indicate this on the meeting registration form.
  2. Submit your e-poster on this website through the online submission portal.


Please note, within the submission portal, you will be able choose and download a PowerPoint slide template. To download the templates to create your e-poster, click on the links below:

General Information and Policies:

  • Lead authors on all submissions are required to register for the conference and pay the applicable registration and poster fee.
  • Residents, fellows and students participating in the Poster Competition are required to present their poster in the Poster Hall on either Friday, February 17 or Saturday, February 18. All other pathologists submitting posters are not required to present their poster but are encouraged to be participate during poster viewing hours to answer questions from conference attendees.
  • Lead authors on all submissions are required to pay a $50 submission fee for each poster. Multiple posters may be submitted.
  • It is the responsibility of the submitter to ensure that his/her poster is submitted correctly.
  • Full disclosure of all authors must be provided by the time of submission. Any failure to fully comply with this requirement may result in the poster being withdrawn.
  • If judges deem that a poster must be edited or updated to be eligible for presentation, lead authors will be contacted by email.


Content Guidelines
Poster entries can only be accepted electronically and must adhere to the following guidelines:

  • Posters must have one central theme, include essential data and test, and be visually appealing.
  • Posters must be proofread carefully to avoid errors before submission.
  • Posters must contain generic drug names only.
  • Posters must be submitted in clear English with accurate grammar and spelling of quality suitable for publication.
  • Lead and secondary authors must disclose all financial relationships.
  • Any funding support for the research must be disclosed.
  • Encore research is not eligible for submission.
  • A maximum of 4 references are allowed.
  • Posters must not contain hyperlinks, videos, GIF files, and must be one slide only.


You will be asked for the following:

  • Short poster title (40-character title for use on onsite signage)
  • Author name(s)
  • Financial disclosures
  • Disclosure of funding support
  • Topic
  • Payment of registration and submission fee


The online poster submission does not allow you to save and return to resume later. Therefore, before starting your submission, have all materials and information ready. After the poster is submitted, you will receive an automated email to confirm your submission. If you do not receive the email within 24 hours, please contact the FSP office at posters@flpath.org or call 904-309-6261.


Poster Topics
The poster must relate to an appropriate topic in the field of pathology. Poster authors will be required to indicate which topic BEST matches the content of their poster. Topics are:

  • Blood Banking/Transfusion Medicine
  • Chemical Pathology
  • Clinical Informatics
  • Cytopathology
  • Dermatopathology
  • Forensic Pathology
  • Hematopathology
  • Medical Microbiology
  • Molecular Genetic Pathology
  • Neuropathology
  • Pediatric Pathology
  • Selective Pathology
  • Case Study
  • Other


Poster Competition Eligibility
Authors must be a resident or fellow enrolled in a full-time approved training program in pathology or sub-specialty of pathology to be eligible to participate in the FSP Poster Competition.


Poster Competition Presentation Process and Awards
Posters submitted for the Poster Competition by residents and fellows will be pre-judged and selected by FSP judges based on quality, innovation, approach/design, and visuals. Posters will be judged twice and are subject to an additional preliminary review to determine eligibility. If judges deem that changes need to be made for posters to be eligible for presentation, lead authors will be contacted by email. The first judging will be done before the conference, and it will be a blind review. The second judging will be conducted during the poster presentation live at the conference in the FSP Poster Hall. The scores from both judging sessions will be combined to determine the winners. The first-place winner will receive $500, the second-place winner will receive $250, and the third-place winner will receive $150. To be considered for the competition, you must you must be a resident or fellow and you must submit your poster by the submission deadline. 

Onsite judging times will be assigned for residents and fellows that are participating in the Poster Competition, and authors will be notified of their presentation time. Presentation times will occur on Friday, February 17 and Saturday, February 18 so please make plans to be available on both days. All lead poster authors are required to register for the conference taking place on February 17-19, 2023 at Disney's Contemporary Resort in Orlando to present their poster to judges.*

Winners of the Poster Competition will be announced, and prizes will be awarded on Saturday, February 18.


The FSP will not be responsible for submissions not received via the website or for submission errors caused by Internet service outages, hardware or software delays, power outages, or unforeseen events. Faxed, emailed or mailed hard-copy posters or posters sent on a CD/disc WILL NOT be accepted. If you have questions, please contact the FSP office at posters@flpath.org or call 904-309-6261.


*Expenses related to registration, airfare, lodging, and social events/guest fees are the responsibility of the presenter.


Networking Events




Confirmed Sponsors

Coming soon

Rare and Interesting Case Competition


Pathology is fun, but it can also be hard! Every day, we are faced with challenging cases that require us to open books, read new articles, consult our friends and colleagues, and sometimes consult the experts. To share such cases with our membership, we will be holding our 2nd annual Rare & Interesting Case Competition at our winter FSP meeting and we need your help!
Community pathologists, junior faculty, and trainees with a faculty mentor are all encouraged to submit their rare and interesting cases for a chance to present at the FSP 2023 Annual Meeting.

The submission window has closed. We will announce the top 5 cases soon!